242 related articles for article (PubMed ID: 21368716)
1. Effects of the α7 nicotinic acetylcholine receptor agonist GTS-21 on the innate immune response in humans.
Kox M; Pompe JC; Gordinou de Gouberville MC; van der Hoeven JG; Hoedemaekers CW; Pickkers P
Shock; 2011 Jul; 36(1):5-11. PubMed ID: 21368716
[TBL] [Abstract][Full Text] [Related]
2. Selective alpha7-nicotinic acetylcholine receptor agonist GTS-21 improves survival in murine endotoxemia and severe sepsis.
Pavlov VA; Ochani M; Yang LH; Gallowitsch-Puerta M; Ochani K; Lin X; Levi J; Parrish WR; Rosas-Ballina M; Czura CJ; Larosa GJ; Miller EJ; Tracey KJ; Al-Abed Y
Crit Care Med; 2007 Apr; 35(4):1139-44. PubMed ID: 17334244
[TBL] [Abstract][Full Text] [Related]
3. GTS-21 inhibits pro-inflammatory cytokine release independent of the Toll-like receptor stimulated via a transcriptional mechanism involving JAK2 activation.
Kox M; van Velzen JF; Pompe JC; Hoedemaekers CW; van der Hoeven JG; Pickkers P
Biochem Pharmacol; 2009 Oct; 78(7):863-72. PubMed ID: 19576181
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of alpha 7 cholinergic receptors inhibits lipopolysaccharide-induced neutrophil recruitment by a tumor necrosis factor alpha-independent mechanism.
Giebelen IA; van Westerloo DJ; LaRosa GJ; de Vos AF; van der Poll T
Shock; 2007 Apr; 27(4):443-7. PubMed ID: 17414429
[TBL] [Abstract][Full Text] [Related]
5. Local stimulation of alpha7 cholinergic receptors inhibits LPS-induced TNF-alpha release in the mouse lung.
Giebelen IA; van Westerloo DJ; LaRosa GJ; de Vos AF; van der Poll T
Shock; 2007 Dec; 28(6):700-3. PubMed ID: 17621262
[TBL] [Abstract][Full Text] [Related]
6. α7 nicotinic acetylcholine receptor agonist GTS-21 attenuates ventilator-induced tumour necrosis factor-α production and lung injury.
Kox M; Pompe JC; Peters E; Vaneker M; van der Laak JW; van der Hoeven JG; Scheffer GJ; Hoedemaekers CW; Pickkers P
Br J Anaesth; 2011 Oct; 107(4):559-66. PubMed ID: 21771746
[TBL] [Abstract][Full Text] [Related]
7. GTS-21 reduces microvascular permeability during experimental endotoxemia.
Schmidt K; Bhakdisongkhram S; Uhle F; Philipsenburg C; Zivkovic AR; Brenner T; Motsch J; Weigand MA; Hofer S
Microvasc Res; 2018 Jan; 115():75-82. PubMed ID: 28818494
[TBL] [Abstract][Full Text] [Related]
8. The α7 nicotinic acetylcholine receptor ligands methyllycaconitine, NS6740 and GTS-21 reduce lipopolysaccharide-induced TNF-α release from microglia.
Thomsen MS; Mikkelsen JD
J Neuroimmunol; 2012 Oct; 251(1-2):65-72. PubMed ID: 22884467
[TBL] [Abstract][Full Text] [Related]
9. The anti-inflammatory potential of selective cholinergic agonists.
Ulloa L
Shock; 2011 Jul; 36(1):97-8. PubMed ID: 21677557
[No Abstract] [Full Text] [Related]
10. GTS-21 has cell-specific anti-inflammatory effects independent of α7 nicotinic acetylcholine receptors.
Garg BK; Loring RH
PLoS One; 2019; 14(4):e0214942. PubMed ID: 30947238
[TBL] [Abstract][Full Text] [Related]
11. The structural basis for GTS-21 selectivity between human and rat nicotinic alpha7 receptors.
Stokes C; Papke JK; Horenstein NA; Kem WR; McCormack TJ; Papke RL
Mol Pharmacol; 2004 Jul; 66(1):14-24. PubMed ID: 15213292
[TBL] [Abstract][Full Text] [Related]
12. Hydroxy metabolites of the Alzheimer's drug candidate 3-[(2,4-dimethoxy)benzylidene]-anabaseine dihydrochloride (GTS-21): their molecular properties, interactions with brain nicotinic receptors, and brain penetration.
Kem WR; Mahnir VM; Prokai L; Papke RL; Cao X; LeFrancois S; Wildeboer K; Prokai-Tatrai K; Porter-Papke J; Soti F
Mol Pharmacol; 2004 Jan; 65(1):56-67. PubMed ID: 14722237
[TBL] [Abstract][Full Text] [Related]
13. GTS-21 attenuates lipopolysaccharide-induced inflammatory cytokine production in vitro by modulating the Akt and NF-κB signaling pathway through the α7 nicotinic acetylcholine receptor.
Yue Y; Liu R; Cheng W; Hu Y; Li J; Pan X; Peng J; Zhang P
Int Immunopharmacol; 2015 Dec; 29(2):504-512. PubMed ID: 26490221
[TBL] [Abstract][Full Text] [Related]
14. GTS-21 Protected Against LPS-Induced Sepsis Myocardial Injury in Mice Through α7nAChR.
Kong W; Kang K; Gao Y; Liu H; Meng X; Cao Y; Yang S; Liu W; Zhang J; Yu K; Zhao M
Inflammation; 2018 Jun; 41(3):1073-1083. PubMed ID: 29680908
[TBL] [Abstract][Full Text] [Related]
15. Role of α7 nicotinic acetylcholine receptors in regulating tumor necrosis factor-α (TNF-α) as revealed by subtype selective agonists.
Li J; Mathieu SL; Harris R; Ji J; Anderson DJ; Malysz J; Bunnelle WH; Waring JF; Marsh KC; Murtaza A; Olson LM; Gopalakrishnan M
J Neuroimmunol; 2011 Oct; 239(1-2):37-43. PubMed ID: 21911260
[TBL] [Abstract][Full Text] [Related]
16. Macrophage migration inhibitory factor (MIF) in meningococcal septic shock and experimental human endotoxemia.
Sprong T; Pickkers P; Geurts-Moespot A; van der Ven-Jongekrijg J; Neeleman C; Knaup M; Leroy D; Calandra T; van der Meer JW; Sweep F; van Deuren M
Shock; 2007 May; 27(5):482-7. PubMed ID: 17438452
[TBL] [Abstract][Full Text] [Related]
17. Analysis of 3-(4-hydroxy, 2-Methoxybenzylidene)anabaseine selectivity and activity at human and rat alpha-7 nicotinic receptors.
Meyer EM; Kuryatov A; Gerzanich V; Lindstrom J; Papke RL
J Pharmacol Exp Ther; 1998 Dec; 287(3):918-25. PubMed ID: 9864273
[TBL] [Abstract][Full Text] [Related]
18. Thalidomide suppressed interleukin-6 but not tumor necrosis factor-alpha in volunteers with experimental endotoxemia.
Shannon E; Noveck R; Sandoval F; Kamath B; Kearney M
Transl Res; 2007 Nov; 150(5):275-80. PubMed ID: 17964516
[TBL] [Abstract][Full Text] [Related]
19. Effects of a cytokine inhibitor, JTE-607, on the response to endotoxin in healthy human volunteers.
Borozdenkova S; Mant TG; Allen E; Pu K; Hoshino S; Jurcevic S
Int Immunopharmacol; 2011 Nov; 11(11):1837-43. PubMed ID: 21820084
[TBL] [Abstract][Full Text] [Related]
20. Cardioprotective role of GTS-21 by attenuating the TLR4/NF-κB pathway in streptozotocin-induced diabetic cardiomyopathy in rats.
Youssef ME; Abdelrazek HM; Moustafa YM
Naunyn Schmiedebergs Arch Pharmacol; 2021 Jan; 394(1):11-31. PubMed ID: 32776158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
